Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Alpha-1 Antitrypsin Deficiency.

Stoller JK, Lacbawan FL, Aboussouan LS.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2006 Oct 27 [updated 2017 Jan 19].

2.

Alpha-1 antitrypsin deficiency: An underrecognized, treatable cause of COPD.

Stoller JK.

Cleve Clin J Med. 2016 Jul;83(7):507-14. doi: 10.3949/ccjm.83a.16031. Review.

3.

Leptin Resistance: A Possible Interface Between Obesity and Pulmonary-Related Disorders.

Rehman Khan A, Awan FR.

Int J Endocrinol Metab. 2016 Feb 12;14(1):e32586. doi: 10.5812/ijem.32586. eCollection 2016 Jan. Review.

4.

Inhaled protein/peptide-based therapies for respiratory disease.

Fellner RC, Terryah ST, Tarran R.

Mol Cell Pediatr. 2016 Dec;3(1):16. doi: 10.1186/s40348-016-0044-8. Epub 2016 Apr 20. Review.

5.

Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.

Lange P, Halpin DM, O'Donnell DE, MacNee W.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss:3-12. doi: 10.2147/COPD.S85976. eCollection 2016. Review.

6.

Liver tumors in children with metabolic disorders.

Schady DA, Roy A, Finegold MJ.

Transl Pediatr. 2015 Oct;4(4):290-303. doi: 10.3978/j.issn.2224-4336.2015.10.08. Review.

7.

T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin.

Baranovski BM, Freixo-Lima GS, Lewis EC, Rider P.

Biomed Res Int. 2015;2015:184574. doi: 10.1155/2015/184574. Epub 2015 Oct 25. Review.

8.

Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.

Kirwan A, Utratna M, O'Dwyer ME, Joshi L, Kilcoyne M.

Biomed Res Int. 2015;2015:490531. doi: 10.1155/2015/490531. Epub 2015 Oct 5. Review.

9.

Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations.

Lane CR, Tonelli AR.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 9;10:2137-46. doi: 10.2147/COPD.S78677. eCollection 2015. Review.

10.

Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Wozniak J, Wandtke T, Kopinski P, Chorostowska-Wynimko J.

Hum Gene Ther. 2015 Nov;26(11):709-18. doi: 10.1089/hum.2015.044. Epub 2015 Sep 29. Review.

11.

Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores.

von Nussbaum F, Li VM.

Bioorg Med Chem Lett. 2015 Oct 15;25(20):4370-81. doi: 10.1016/j.bmcl.2015.08.049. Epub 2015 Aug 20. Review.

12.

The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.

Twigg MS, Brockbank S, Lowry P, FitzGerald SP, Taggart C, Weldon S.

Mediators Inflamm. 2015;2015:293053. doi: 10.1155/2015/293053. Epub 2015 Jun 21. Review.

13.

Aerosolized Medications for Gene and Peptide Therapy.

Laube BL.

Respir Care. 2015 Jun;60(6):806-21; discussion 821-4. doi: 10.4187/respcare.03554. Review.

14.

Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.

Gruntman AM, Flotte TR.

Hum Gene Ther Methods. 2015 Jun;26(3):77-81. doi: 10.1089/hgtb.2015.086. Review.

15.

Suspecting and Testing for Alpha-1 Antitrypsin Deficiency-An Allergist's and/or Immunologist's Perspective.

Craig TJ.

J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):506-11. doi: 10.1016/j.jaip.2015.04.005. Epub 2015 May 29. Review.

16.

Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.

Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ.

Lancet. 2015 May 2;385(9979):1789-98. doi: 10.1016/S0140-6736(15)60693-6. Review.

17.

The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Goldberg DS, Fallon MB.

Clin Gastroenterol Hepatol. 2015 Nov;13(12):2118-27. doi: 10.1016/j.cgh.2015.04.024. Epub 2015 Apr 28. Review.

18.

Cirrhosis in children and adolescents: An overview.

Pinto RB, Schneider AC, da Silveira TR.

World J Hepatol. 2015 Mar 27;7(3):392-405. doi: 10.4254/wjh.v7.i3.392. Review.

19.

Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm.

McElvaney NG.

Eur Respir Rev. 2015 Mar;24(135):52-7. doi: 10.1183/09059180.10010814. Review.

20.

Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy.

Teschler H.

Eur Respir Rev. 2015 Mar;24(135):46-51. doi: 10.1183/09059180.10010714. Review.

Supplemental Content

Loading ...
Support Center